General Range
OVATUNE
Price on request/100 · MOQ 100 boxes
OVATUNE Tablets by Fortune Labs contain Dehydroepiandrosterone (DHEA) Sustained Release, Folic Acid and Vitamin D3, a hormonal and nutritional combination marketed for selected women's reproductive health requirements. DHEA is a naturally occurring steroid hormone precursor investigated for its potential role in certain fertility-related conditions, although clinical benefits remain uncertain. Folic Acid supports normal cell division and contributes to healthy foetal neural tube development, while Vitamin D3 helps regulate calcium absorption and bone metabolism. OVATUNE may be considered only when its ingredients are clinically appropriate and authorised for the intended use. Available in tablet blister packaging, this formulation requires medical supervision, particularly regarding hormonal effects, fertility treatment, pregnancy planning, contraindications and potential drug interactions.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Dehydroepiandrosterone (Sustained Release), Folic Acid & Vitamin D3 Tablets
- Packaging Type
- Tablet Blister Strips with Printed Carton Box
- Packaging Size
- 10 × 10
- Dosage Form
- Tablet
- Treatment
- DHEA has been studied in selected fertility-related conditions, but benefits remain uncertain.
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
